Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
24.08
-0.59 (-2.37%)
Nov 16, 2026, 4:00 PM EST - Market closed

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $90.41M in the quarter ending September 30, 2026, with 7.54% growth. This brings the company's total for the last twelve months to $330.28M, up 4.67% year-over-year. In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth. That makes Fulgent Genetics the 13,850th largest company in the world by revenue and 2,549th in the United States.

Revenue (ttm)
$330.28M
Revenue Growth
+4.67%
P/S Ratio
2.04
Revenue / Employee
$251,160
Employees
1,315
Market Cap
672.63M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Laboratory Services 322.22M 99.9%
  • Therapeutic Development 447.00K 0.1%

By Geography

Chart
  • United States 296.55M 91.9%
  • Other Countries 13.21M 4.1%
  • China 12.91M 4.0%
Fiscal year ended Dec 31, 2025 See the full Fulgent Genetics breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025322.67M39.20M13.83%
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics803.60M
NeoGenomics787.75M
OPKO Health654.10M
Veracyte581.78M
CareDx497.40M
GeneDx Holdings460.78M
Castle Biosciences377.13M
Freenome217.86M
Revenue Rankings